Research spearheaded by the Center and Amprion Pharmaceutical identified a sub-group of sporadic ALS patients in whom a self-replicating protein was detected in spinal fluid. The implication of this finding for the treatment of patients will be the focus of the Center's research.
top of page
News
At the invitation of James Wymer, M.D., Dr. Smith presented Neurology Grand Rounds at the University of Florida at Gainesville. Subsequently, he visited with faculty members which may result in a collaboration between our institutions. A recording of his presentation will be uploaded as soon as it is available.
La Jolla Light and San Diego Business Journal recently reported upon the approval of Qalsody (tofersen). See links below or the pdf file.
La Jolla Light: https://www.lajollalight.com/news/story/2023-05-06/la-jolla-scientists-help-develop-drug-approved-to-treat-genetic-als
San Diego Business Journal: https://www.sdbj.com/life-sciences/pharmaceuticals/fda-oks-new-als-drug/
bottom of page